Imaging the Core on NCCT:
Unlocking Stroke Insights Across Networks
Thursday, April 24th, 9am PST | 12PM EST
Dr Mehdi Bouslama
Interventional Neurologist,
at Broward Health, Florida
Dr Kambiz Nael
Brainomix isn’t just enhancing stroke care, it’s changing expectations. The FDA clearance of the core volume feature enables physicians to assess ischemic core volume from universally available non-contrast CT (NCCT) scans through the Brainomix 360 Stroke solution, generating expert-level insights equivalent to CT Perfusion and MRI-derived assessments that can improve decision making for treatment and transfer of patients.
In this webinar, you'll discover:
- How smarter AI translates ordinary scans into extraordinary insights, transforming treatment decisions.
- The proven impact of Core Volume quantification directly from non-contrast CT (NCCT) scans, enhancing speed and precision in stroke triage.
- Real-world evidence demonstrating how our technology strengthens stroke networks, reduces treatment delays, significantly improves treatment rates & patient outcomes.
Smarter AI = Stronger Stroke Teams
Your team’s expertise combined with our AI’s precision pushes the limits of what’s possible in stroke care. Join our webinar to see how we help you See More. Do More. Save More.
The Webinar will start in
- 00 Days
- 00 Hours
- 00 Minutes
Reserve your spot now and see firsthand how Brainomix empowers your stroke team to deliver expert-level care, anywhere, anytime.
To schedule a demo or learn more about Brainomix in the US:
us-info@brainomix.com
Brad Wittenberg
Director, US Commercial Sales & Partnership
bwittenberg@brainomix.com
BRAINOMIX USA INC.
Correspondence address:
101 W. Grand, Suite 200,
Chicago, Illinois 60654
Registered address: Corporation Trust Center, 1209 Orange Street, Wilmington, DE 19801
Brainomix USA Inc. is a company registered in Delaware USA
© 2026 BRAINOMIX USA INC. All Rights Reserved.